Revvity, Inc. (RVTY)
NYSE: RVTY · IEX Real-Time Price · USD
108.15
-1.65 (-1.50%)
At close: Jul 19, 2024, 4:00 PM
108.08
-0.07 (-0.06%)
After-hours: Jul 20, 2024, 12:58 PM EDT

Revvity Market Cap

Revvity has a market cap or net worth of $13.34 billion as of July 22, 2024. Its market cap has decreased by -8.19% in one year.

Market Cap
13.34B
Enterprise Value
15.65B
1-Year Change
-8.19%
Ranking
Category
Stock Price
$108.15

Market Cap Chart

Since December 1, 1998, Revvity's market cap has increased from $1.28B to $13.34B, an increase of 940.38%. That is a compound annual growth rate of 9.56%.

History

DateMarket Cap% Change
Jul 19, 202413.35B-1.07%
Dec 29, 202313.49B-23.84%
Dec 30, 202217.71B-30.20%
Dec 31, 202125.37B57.91%
Dec 31, 202016.07B48.95%
Dec 31, 201910.79B23.46%
Dec 31, 20188.74B8.41%
Dec 29, 20178.06B41.08%
Dec 30, 20165.71B-4.73%
Dec 31, 20156.00B21.39%
Dec 31, 20144.94B6.60%
Dec 31, 20134.63B27.20%
Dec 31, 20123.64B61.08%
Dec 30, 20112.26B-25.79%
Dec 31, 20103.05B26.77%
Dec 31, 20092.40B46.34%
Dec 31, 20081.64B-46.73%
Dec 31, 20073.08B12.83%
Dec 29, 20062.73B-11.29%
Dec 30, 20053.08B6.97%
Dec 31, 20042.88B33.04%
Dec 31, 20032.17B107.75%
Dec 31, 20021.04B-70.73%
Dec 31, 20013.56B-32.07%
Dec 29, 20005.24B172.32%
View and export this data all the way back to 1998. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Neurocrine Biosciences 14.66B
United Therapeutics 14.60B
Viatris 14.10B
Sarepta Therapeutics 13.76B
Insulet 13.66B
Medpace Holdings 13.05B
Tenet Healthcare 13.02B
Natera 13.01B
Market Cap Rankings